Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type

Journal of Urology

Volumn 157, Issue 6, 1997, Pages 2345-2350

  Ramp, Uwe ^b   Jaquet, Kai ^b   Reinecke, Petra ^b   Schardt, Cordula ^b   Friebe, Ulrike ^b   Nitsch, Thorsten ^b   Marx, Nikolaus ^b   Gabbert, Helmut Erich ^b   Gerharz, Claus Dieter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NONE

Author keywords

growth factor receptors; growth factors; human renal cell carcinoma; signal transduction pathways

Indexed keywords

GROWTH FACTOR; GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; AUTOCRINE EFFECT; CLEAR CELL CARCINOMA; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KIDNEY CARCINOMA; NORTHERN BLOTTING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030900916     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64778-5     Document Type: Article

References (32)

1. Damjanov, I.: Growth factor receptors. In: Current Topics in Pathology, Vol 83. Edited by C. L. Berry, and E. Grundmann. Berlin, Heidelberg, New York: Springer Verlag: pp. 159-186, 1991.
2. Brinkmann, U. and Pastan, I.: Immunotoxins against cancer. Biochim. Biophys. Acta, 1198: 27, 1994.
3. Gomella, L. G., Sargent, E. R., Linehan, W. M. and Kasid, A.: Transforming growth factor-beta inhibits the growth of renal cell carcinoma in vitro. J. Urol., 141: 1240, 1989.
4. Gomella, L. G., Sargent, E. R., Wade, T. P., Anglard, P., Linehan, W. M. and Kasid, A.: Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma. Cancer Res., 49: 6972, 1989.
5. Petrides, P. E., Bock, S., Bovens, J., Hofmann, R. and Jakse, G.: Modulation of pro-epidermal growth factor, pro-transforming growth factor alpha and epidermal growth factor receptor gene expression in human renal carcinomas. Cancer Res., 50: 3934, 1990.
6. Walker, C., Everitt, J., Freed, J. J., Knudson, A. G., Jr. and Whiteley, L. O.: Altered expression of transforming growth factor-alpha in hereditary rat renal cell carcinoma. Cancer Res., 51: 2973, 1991.
7. Sovova, V., Sloncova, E., Damkova, M., Vydra, J. and Jakoubkova, J.: Activity of PDGF (A) gene in the human cell line derived from a renal carcinoma metastasis. Folia Biologica, 39: 40, 1993.
8. Mostofi, F. K.: Histological typing of kidney tumours. International Histologic Classification of Tumors. Geneva: World Health Organization, 1981.
9. Thoenes, W., Störkel, S. and Rumpelt, H. J.: Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). Path. Res. Pract., 181: 125, 1986.
10. Kovacs, G. and Frisch, S.: Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res., 49: 651, 1989.
11. Störkel, S., Thoenes, W., Jacobi, G. H. and Lippold, R.: Prognostic parameters in renal cell carcinoma - a new approach. Eur. Urol., 16: 416, 1989.
12. Gerharz, C. D., Moll, R., Störkel, S., Ramp, U., Thoenes, W. and Gabbert, H. E.: Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic and chromophobe cell variants of human renal cell carcinoma in vivo and in vitro. Am. J. Pathol., 142: 851, 1993.
13. Gerharz, C. D., Moll, R., Störkel, S., Ramp, U., Hildebrandt, B., Molsberger, G., Koldovsky, P. and Gabbert, H. E.: Establishment and characterization of two divergent cell lines derived from a human chromophobe renal cell carcinoma. Am. J. Pathol., 146: 953, 1995.
14. Gerharz, C. D., Ramp, U., Olert, J., Moll, R., Störkel, S., Marx, N. and Gabbert, H. E.: Cytomorphological, cytogenetic, and molecular biological characterization of four new human renal carcinoma cell lines of the clear cell type. Virchows Arch. B., 424: 403, 1994.
15. Goodyer, P. R., Cybulsky, A. and Goodyer, C.: Expression of the epidermal growth factor receptor in fetal kidney. Pediatr. Nephrol., 7: 612, 1993.
16. Folkman, J. and Klagsbrun, M.: Angiogenic factors. Science, 235: 442, 1987.
17. Jarrard, D. F., Blitz, B. F., Smith, R. C., Patai, B. L. and Rukstalis, D. B.: Effect of epidermal growth factor on prostate cancer cell line PCS growth and invasion. Prostate, 24: 46, 1994.
18. Otani, N., Tsukamoto, T., Masumori, N., Saiki, I., Yoneda, J. and Kumamoto, Y.: Influence of growth factors on in vitro invasiveness and type IV collagenolysis of human renal cell carcinoma cells. J. Urol., 151: 223, 1994.
19. Yudoh, K., Matsui, H., Kanamori, M., Maeda, A., Ohmori, K. and Tsuji, H.: Effects of epidermal growth factor on invasiveness through the extracellular matrix in high- and low-metastatic clones of RCT sarcoma in vitro. Jpn. J. Cancer Res., 85: 63, 1994.
20. Bennington, J. L., Strathearn, M., Spencer, E. M. and Williams, R. D.: Implications of insulin-like growth factors in renal cell carcinoma. Eur. Urol., 18: 13, 1990.
21. Barnard, J. A., Lyons, R. M. and Moses, H. L.: The cell biology of transforming growth factor beta. Biochim. Biophys. Acta, 1032: 79, 1990.
22. Creely, J. J., Dimari, S. J., Howe, A. M. and Haralson, M. A.: Effects of transforming growth factor-beta on collagen synthesis by normal rat kidney epithelial cells. Am. J. Pathol., 140: 45, 1992.
23. Moustakas, A., Lin, H. Y., Henis, Y. I., Plamondon, J., O'Connor-McCourt, M. D. and Lodish, H. F.: The transforming growth factor β receptors types I, II, and III form heterooligomeric complexes in the presence of ligand. J. Biol. Chem., 268: 22215, 1993.
24. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F. and Massague, J.: Mechanism of activation of the TGF-beta receptor. Nature, 370: 341, 1994.
25. Roberts, A. B. and Sporn, M. B.: The transforming growth factor-betas. Peptide growth factors and their receptors. In: Handbook of Experimental Pharmacology. Edited by M. B. Sporn and A. B. Roberts. Heidelberg: Springer Verlag, pp. 419-472, 1990.
26. Stampfer, M. R., Yaswen, P., Alhadeff, M. and Hosoda, J.: TGF β induction of extracellular matrix associated proteins in normal and transformed human mammary epithelial cells in culture is independent of growth effects. J. Cellular Physiol., 155: 210, 1993.
27. 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma. J. Neurosurg., 78: 944, 1993.
28. 1 on in vitro angiogenesis. Exp. Cell Res., 204: 356, 1993.
29. Helseth, E., Dalen, A., Unsgaard, G., Vik, R. and Helseth, A.: Overexpression of the epidermal growth factor gene in a human carcinoma cell line, derived from a brain metastasis. J. Neurooncol., 7: 81, 1989.
30. Ishikawa, J., Maeda, S., Umezu, K., Sugiyama, T. and Kamidono, S.: Amplification and overexpression of the epidermal growth factor receptor gene in human renal-cell carcinoma. Int. J. Cancer, 45: 1018, 1990.
31. 1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor. Br. J. Cancer, 69: 802, 1994.
32. Dijke, P., Yamashita, H., Ichijo, H., Franzen, P., Laiho, M., Miyazono, K. and Heldin, C.-H.: Characterization of type I receptors for transforming growth factor-beta and activin. Science, 264: 101, 1994.